(A) Female and male body weight change over the course of 16 weeks for FXR hep flox/flox and FXR hep-/- (B) Female and male liver-to-body weight ratios; (C) H&E stained liver sections (n=3–6); (D) ...
Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...
Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 3 reviews the use of GLP-1 receptor agonists and tobacco use. A variety of ...
Exenatide is a generic prescription drug approved to help manage blood sugar levels in adults with type 2 diabetes. It’s not available in a brand-name version. Exenatide comes as a liquid solution ...
GitHub Copilot continues to evolve in both Visual Studio and Visual Studio Code, offering developers increasingly intelligent, context-aware tools that go far beyond basic autocomplete. The latest ...
Chad Thesen is a passionate fan of anime, video games, series, and films (Both animated and live-action). Many years of experience have left him with a deep knowledge of these mediums' intricacies and ...
Drug-induced liver injury (DILI) is a harmful reaction to medications, herbs, and dietary supplements that results in liver dysfunction. Based on the distinct clinical patterns of liver damage, DILI ...
Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary supplements. It can manifest in different forms, including hepatocellular, ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. The finding contrasts with positive results from previous phase II studies ...
Findings showed MDS-UPDRS OFF medication scores had worsened (increased) by 5.7 points in exenatide-treated patients compared with a 4.5 point increase with placebo. Treatment with once-weekly ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Previous studies suggest GLP-1 receptor agonists may ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers. The world's largest and longest trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results